Cargando…
ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs
INTRODUCTION: Antigen-specific immunotherapy could provide a targeted approach for the treatment of multiple sclerosis that removes the need for broad-acting immunomodulatory drugs. ATX-MS-1467 is a mixture of four peptides identified as the main immune-dominant disease-associated T-cell epitopes in...
Autores principales: | De Souza, Adriano Luís Soares, Rudin, Stefan, Chang, Rui, Mitchell, Keith, Crandall, Timothy, Huang, Shuning, Choi, Ji-Kyung, Okitsu, Shinji L., Graham, Danielle L., Tomkinson, Blake, Dellovade, Tammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990509/ https://www.ncbi.nlm.nih.gov/pubmed/29542041 http://dx.doi.org/10.1007/s40120-018-0094-z |
Ejemplares similares
-
Preclinical development and first-in-human study of ATX-MS-1467 for immunotherapy of MS
por: Streeter, Heather B., et al.
Publicado: (2015) -
In-vitro inhibition of IFNγ(+) iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function
por: Daniel, Volker, et al.
Publicado: (2012) -
Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways
por: Lu, Yunjie, et al.
Publicado: (2014) -
Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
por: Hui, Zhenzhen, et al.
Publicado: (2021) -
Cholesterol suppresses human iTreg differentiation and nTreg function through mitochondria-related mechanisms
por: Zhang, Huanzhi, et al.
Publicado: (2023)